The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Aug. 28, 2008
Applicants:

Teiji Kimura, Tsukuba, JP;

Noritaka Kitazawa, Tsukuba, JP;

Toshihiko Kaneko, Tsukuba, JP;

Nobuaki Sato, Tsukuba, JP;

Koki Kawano, Tsukuba, JP;

Koichi Ito, Tsukuba, JP;

Mamoru Takaishi, Tsukuba, JP;

Takeo Sasaki, Tsukuba, JP;

Yu Yoshida, Tsukuba, JP;

Toshiyuki Uemura, Tsukuba, JP;

Takashi Doko, Tsukuba, JP;

Daisuke Shinmyo, Tsukuba, JP;

Daiju Hasegawa, Tsukuba, JP;

Takehiko Miyagawa, Hatfield, GB;

Hiroaki Hagiwara, Tsukuba, JP;

Inventors:

Teiji Kimura, Tsukuba, JP;

Noritaka Kitazawa, Tsukuba, JP;

Toshihiko Kaneko, Tsukuba, JP;

Nobuaki Sato, Tsukuba, JP;

Koki Kawano, Tsukuba, JP;

Koichi Ito, Tsukuba, JP;

Mamoru Takaishi, Tsukuba, JP;

Takeo Sasaki, Tsukuba, JP;

Yu Yoshida, Tsukuba, JP;

Toshiyuki Uemura, Tsukuba, JP;

Takashi Doko, Tsukuba, JP;

Daisuke Shinmyo, Tsukuba, JP;

Daiju Hasegawa, Tsukuba, JP;

Takehiko Miyagawa, Hatfield, GB;

Hiroaki Hagiwara, Tsukuba, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/437 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); C07D 403/10 (2006.01); A61P 25/28 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/10 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract

Disclosed is a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, which is effective as a therapeutic or prophylactic agent for a disease induced by Aβ, wherein Arrepresents an imidazolyl group which may be substituted with a C1-6 alkyl group, or the like; Arrepresents a phenyl group which may be substituted with a C1-6 alkoxy group, or the like; Xrepresents a double bond, or the like; and Het represents a triazolyl group or the like which may be substituted with a C1-6 alkyl group or the like, or the like.


Find Patent Forward Citations

Loading…